Full name
CLINICAL RESEARCH GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CLINICAL RESEARCH GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. SOKOŁOWSKA 9 / U-2, 01-142 WARSZAWA
TAX ID7010358971
Rate company:
CLINICAL RESEARCH GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7010358971
KRS0000437034
Share capital100,000.00 zł
address
UL. SOKOŁOWSKA 9 / U-2, 01-142 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7010358971
REGON
146329882
KRS
0000437034
Legal form
limited liability company
Register Address
UL. SOKOŁOWSKA 9 / U-2, 01-142 WARSZAWA
Date of registration in KRS
2012-10-18
Date of commencement of economic activity
2012-10-18
Act signature
RDF/627322/24/861
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
63.11.Z - Data processing, hosting and related activities
70.2 - Management consultancy activities
72.1 - Research and experimental development on natural sciences and engineering
74.3 - Translation and interpretation activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.90.D - Paramedical activities
Payer VAT status
Active
Vat list bank account(s)
PL62 1020 1055 0000 9502 0295 0509 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0 | 0,2 | 0,3 | 41,2 |
EBITDA | -0 | 0,2 | 0,3 | 56,2 |
Short time liabilities | 0,2 | 0,1 | 0 | -56,6 |
Equity capital | 0,5 | 0,6 | 0,9 | 40,1 |
Operating profit (EBIT) | -0 | 0,2 | 0,3 | 57,2 |
Assets | 0,8 | 0,7 | 0,9 | 28,7 |
Net profit (loss) | -0 | 0,2 | 0,2 | 40,6 |
Cash | 0,2 | 0,2 | 0,3 | 51,9 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | 0 | -56,6 |
Net income from sale | 1,2 | 1 | 1,3 | 27,2 |
Working assets | 0,7 | 0,7 | 0,9 | 29,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -7,7 | 27,4 | 27,5 | 0,1 |
Equity capital to total assets | 70,6 | 88,2 | 96 | 7,8 |
Gross profit margin | -3,4 | 18,3 | 20,3 | 2 |
EBITDA Margin | -2,8 | 17,6 | 21,6 | 4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 30 | 10 | -20 |
Current financial liquidity indicator | 3.3559069633483887 | 8.390567779541016 | 25.0383358001709 | 16,6 |
Net dept to EBITDA | 4.469130516052246 | -0.9434682726860046 | -0.9177873134613037 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
4CAE Krzysztof Matusiak
Warszawa
KATARZYNA PAWEŁCZYK SCINT
Wrocław